European animal vaccine market is estimated to grow at a CAGR of around 5.9% during the forecast period. Due to increasing dependency on non-vegetarian foods such as meat, chicken, pork, and others, Europe is considered to be a significant market for animal husbandry. Transforming agriculture practices and growing reliability on limited crops is augmenting the demand for non-vegetarian food. Therefore, vaccination plays a critical role in maintaining animal health. Veterinary education plays a critical role in curbing animal disease.

With the growing number of TAD (Transboundary Animal Diseases) among the livestock, veterinary establishments have been reported an increase in the European countries. Thus, with the increased TAD, the region is continuously increasing the vaccines for animal welfare purpose. According to World Organization for Animal Health, European countries has reported a total of 145 VEE (Veterinary Education Establishments) in 2017, which generates the substantial need for animal vaccines and as a result, the region contributes a significant share in the global animal vaccine market.

Some crucial players in the European animal vaccine market include Zoetis, Inc., Bayer AG, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Novartis International AG and Vetoquinol S.A. In order to survive in the market, these players are adopting crucial strategies, such as mergers and acquisitions, product launches, and partnerships and collaborations. This enables the company to increase its competitiveness and attract significant share in the market. For instance, in November 2018, Merck & Co., Inc. expanded their warehousing, manufacturing and packaging facility in Milton Keynes, UK site, for filling and blending of poultry vaccines. This expansion would support to leverage the company’s position in the Animal Health market.

Research Methodology

The market study of the European animal vaccine market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market
• Authentic public databases 
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog

The report is intended for pharmaceuticals companies, veterinary companies, government organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models. 

Market Segmentation:

• European Animal Vaccine Market Research and Analysis, By Type
• European Animal Vaccine Market Research and Analysis, By Technology

The Report covers:

• Comprehensive research methodology of the European animal vaccine market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regulations and other government policies impacting the European animal vaccine market.
• Insights about market determinants which are stimulating the European animal vaccine market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.